These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Lavau-Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Vénat-Bouvet L, Labourey JL, Martin J, Slaouti P, Tubiana-Mathieu N. Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449 [Abstract] [Full Text] [Related]
3. Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: a single-institution experience. Grisariu S, Spectre G, Kalish Y, Gatt ME. Eur J Haematol; 2013 May; 90(5):397-403. PubMed ID: 23414485 [Abstract] [Full Text] [Related]
5. Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters. Refaei M, Fernandes B, Brandwein J, Goodyear MD, Pokhrel A, Wu C. Ann Hematol; 2016 Dec; 95(12):2057-2064. PubMed ID: 27542955 [Abstract] [Full Text] [Related]
7. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Büller HR, Bounameaux H. J Thromb Haemost; 2013 Jan; 11(1):71-80. PubMed ID: 23217208 [Abstract] [Full Text] [Related]
10. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients. Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P, Groupe Francophone Thrombose et Cancer (GFTC). Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988 [Abstract] [Full Text] [Related]
11. The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients. Lv S, Liu Y, Wei G, Shi X, Chen S, Zhang X. Medicine (Baltimore); 2019 Nov; 98(47):e17894. PubMed ID: 31764785 [Abstract] [Full Text] [Related]
13. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children. Brandão LR, Shah N, Shah PS. Cochrane Database Syst Rev; 2014 Mar 10; (3):CD005982. PubMed ID: 24615288 [Abstract] [Full Text] [Related]
14. Low molecular weight heparin for deep vein thrombosis in glioma patients. Schmidt F, Faul C, Dichgans J, Weller M. J Neurol; 2002 Oct 10; 249(10):1409-12. PubMed ID: 12382158 [Abstract] [Full Text] [Related]
18. The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities. Greene MT, Flanders SA, Woller SC, Bernstein SJ, Chopra V. Am J Med; 2015 Sep 10; 128(9):986-93.e1. PubMed ID: 25940453 [Abstract] [Full Text] [Related]
20. Central venous catheter-related thrombosis in intensive care patients - incidence and risk factors: A prospective observational study. Hrdy O, Strazevska E, Suk P, Vach R, Karlik R, Jarkovsky J, Sas I, Gal R. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Dec 10; 161(4):369-373. PubMed ID: 28839334 [Abstract] [Full Text] [Related] Page: [Next] [New Search]